https://www.biospace.com/dare-announces-fda-approval-of-xaciato-clindamycin-phosphate-vaginal-gel-as-a-treatment-for-bacterial-vaginosis
Daré Announces FDA Approval of XACIATO™ (clindamycin phosphate) Vaginal Gel as a Treatment for...
Dec 7, 2021 - Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) approved XACIATO...